Fischer Medical Ventures Limited (BOM:524743)
India · Delayed Price · Currency is INR 37.94
-0.74 (-1.91%)
At close: Aug 21, 2026
Fischer Medical Ventures Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,671 | 3,086 | 1,107 | 209.81 | 1.8 | - |
Other Revenue | -59.82 | - | - | - | - | - |
| 3,611 | 3,086 | 1,107 | 209.81 | 1.8 | - | |
Revenue Growth | 191.13% | 178.75% | 427.61% | 11588.75% | 8.79% | - |
Cost of Revenue | 2,410 | 1,956 | 917.59 | 165.76 | - | - |
Gross Profit | 1,200 | 1,130 | 189.4 | 44.05 | 1.8 | - |
Selling, General & Admin | 164.54 | 150.94 | 47 | 5.11 | 0.63 | 0.9 |
Other Operating Expenses | 593.24 | 548.08 | 108.97 | 20.35 | 1.01 | 0.98 |
Operating Expenses | 793.48 | 728.81 | 172.29 | 27.27 | 1.64 | 1.89 |
Operating Income | 406.8 | 401.04 | 17.11 | 16.78 | 0.15 | -1.89 |
Interest Expense | -87.16 | -58.34 | -4.03 | -0.68 | -0.17 | -0.09 |
Interest & Investment Income | - | - | 9.27 | 4.95 | - | - |
Earnings From Equity Investments | 1.12 | - | -4.87 | - | - | - |
Other Non Operating Income (Expenses) | 123.14 | 123.14 | 2.65 | 0.06 | -0 | - |
EBT Excluding Unusual Items | 443.89 | 465.84 | 20.14 | 21.11 | -0.01 | -1.97 |
Pretax Income | 443.89 | 465.84 | 22.23 | 21.11 | -0.01 | -1.97 |
Income Tax Expense | 142.16 | 153.43 | 10.15 | 2.73 | 0.35 | 0.35 |
Net Income | 301.73 | 312.41 | 12.08 | 18.38 | -0.37 | -2.33 |
Net Income to Common | 301.73 | 312.41 | 12.08 | 18.38 | -0.37 | -2.33 |
Net Income Growth | 376.42% | 2486.42% | -34.28% | - | - | - |
Shares Outstanding (Basic) | 657 | 651 | 549 | 111 | 2 | 2 |
Shares Outstanding (Diluted) | 710 | 694 | 549 | 169 | 2 | 2 |
Shares Change | - | 26.45% | 223.98% | 9752.91% | - | - |
EPS (Basic) | 0.46 | 0.48 | 0.02 | 0.17 | -0.21 | -1.35 |
EPS (Diluted) | 0.42 | 0.45 | 0.02 | 0.11 | -0.21 | -1.35 |
EPS Growth | - | 1945.46% | -79.63% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | - | -927.26 | -78.37 | -1.46 | -1.77 |
Free Cash Flow Per Share | - | - | -1.69 | -0.46 | -0.85 | -1.03 |
Dividend Per Share | - | 0.050 | 0.005 | - | - | - |
Dividend Growth | - | 900.00% | - | - | - | - |
Gross Margin | 33.24% | 36.61% | 17.11% | 20.99% | 100.00% | - |
Operating Margin | 11.27% | 13.00% | 1.55% | 8.00% | 8.52% | - |
Profit Margin | 8.36% | 10.12% | 1.09% | 8.76% | -20.33% | - |
Free Cash Flow Margin | - | - | -83.76% | -37.35% | -81.28% | - |
EBITDA | 425.34 | 407.62 | 23.69 | 17.68 | - | - |
EBITDA Margin | 11.78% | 13.21% | 2.14% | 8.43% | - | - |
D&A For EBITDA | 18.54 | 6.58 | 6.58 | 0.91 | - | - |
EBIT | 406.8 | 401.04 | 17.11 | 16.78 | 0.15 | -1.89 |
EBIT Margin | 11.27% | 13.00% | 1.55% | 8.00% | 8.52% | - |
Effective Tax Rate | 32.03% | 32.93% | 45.66% | 12.95% | - | - |
Revenue as Reported | 3,734 | 3,209 | 1,122 | 214.83 | 1.8 | - |